远程医疗行为治疗药物依从性：一项试点和可行性研究。
Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study.
机构信息
Division of Behavioral Medicine and Clinical Psychology, Center for the Promotion of Treatment Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, MLC 7039, Cincinnati, OH 45229-3039, USA.
出版信息
Eur J Gastroenterol Hepatol. 2013 Apr;25(4):469-73. doi: 10.1097/MEG.0b013e32835c2a1b.
OBJECTIVE
To evaluate an individually tailored multicomponent nonadherence treatment protocol using a telehealth delivery approach in adolescents with inflammatory bowel disease.
METHODS
Nine participants, age 13.71±1.35 years, completed a brief treatment online through Skype. Medication nonadherence, severity of disease, and feasibility/acceptability data were obtained.
RESULTS
Adherence increased markedly from 62% at baseline to 91% for mesalamine (δ=0.63), but decreased slightly from 61% at baseline to 53% for 6-mercaptopurine /azathioprine. The telehealth delivery approach resulted in cost savings of $100 in mileage and 4 h of travel time/patient. Treatment session attendance was 100%, and the intervention was rated as acceptable, particularly in terms of treatment convenience.
CONCLUSION
Individually tailored treatment of nonadherence through telehealth delivery is feasible and acceptable. This treatment shows promise for clinical efficacy to improve medication adherence and reduce costs. Large-scale testing is necessary to determine the impact of this intervention on adherence and health outcomes.
目的
评估一种个体化的多组分药物依从性治疗方案，该方案采用远程医疗方式，用于治疗炎症性肠病青少年患者。
方法
9 名年龄在 13.71±1.35 岁的参与者通过 Skype 在线完成了简短的治疗。获取了药物依从性、疾病严重程度和可行性/可接受性数据。
结果
与基线时的 62%相比，美沙拉嗪的依从性显著增加至 91%（δ=0.63），而巯嘌呤/硫唑嘌呤的依从性则从基线时的 61%略有下降至 53%。远程医疗的方式使每位患者节省了 100 美元的里程费和 4 小时的旅行时间。治疗课程的出席率为 100%，干预措施被评为可接受的，特别是在治疗方便性方面。
结论
通过远程医疗方式进行个体化的药物依从性治疗是可行且可接受的。这种治疗方法有望在改善药物依从性和降低成本方面具有临床疗效。需要进行大规模测试，以确定该干预措施对依从性和健康结果的影响。
Zotero 插件